Clinical Chemistry · 1990 · 18 citations · 6 references
MedicineChild HealthPediatricsHepatologyInfant HealthPediatric GastroenterologyChronic Liver DiseaseHepatic Function TestingLiver DiseaseLiver Function TestsPediatric HepatologyPediatric Liver DiseaseAminotransferase RatiosAspartate Aminotransferase ElevationChronic Liver Disease EvaluationLiver Enzyme AbnormalitiesPrognostic Index DevelopmentSerum Alanine AminotransferaseSerum Aminotransferase MonitoringSerum Aspartate Aminotransferase
To assess the utility of the serum aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio in a group of infants with liver disorders, we retrospectively analyzed the charts of 73 infants with chronic liver disorders. Patients were considered as having either a good outcome (n = 40) or a poor outcome (n = 33), based upon the clinical course. AST and ALT in serum were measured simultaneously at the time of initial presentation and at various follow-up visits during the first 13 months after birth. At presentation (mean age 1.65 months), there was no difference in the AST/ALT ratios between the good (1.61 +/- 0.62; mean +/- SD) and poor (1.65 +/- 0.78) outcome groups (P = 0.81). However, over time, the AST/ALT ratio increased in patients in the poor-outcome group and decreased in patients in the good-outcome group. Calculating the AST/ALT ratio appears to be an easy, early, and reliable prognostic indicator for infants with hepatic disease, and may be a useful measure for evaluating liver-disease patients.
6
Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis
Brett Williams, Jay H. Hoofnagle · 1988 · 133 citations
Medicine, Pathology, Hepatology +14
Microchemical analysis for 13 constituents of plasma from healthy children.
Maosheng Cheng, Allen I. Lipsey, Valentina Blanco et al. · Clinical Chemistry · 1979 · 21 citations